Schmitt Nicole C, Sharma Arun, Gilbert Mark R, Kim Seungwon
Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University, Baltimore, Maryland, USA.
Division of Otolaryngology-Head and Neck Surgery, Southern Illinois University, Springfield, Illinois, USA.
Otolaryngol Head Neck Surg. 2015 Nov;153(5):795-8. doi: 10.1177/0194599815601659. Epub 2015 Aug 25.
Salivary duct carcinoma (SDC) is a rare salivary malignancy that often presents at advanced stage. Outcomes of low T stage patients with SDC have not been previously examined in detail. We queried our institution's cancer database and identified 28 patients with SDC in situ or T1/T2 SDC. A retrospective chart review was performed, followed by comparison of clinicopathologic features with N stage, disease-free survival, and overall survival. Patients tended to be male, in their sixties, with a high incidence of regional metastases, as in prior reports. Five-year disease-free and overall survival were 49%. Median disease-free survival was 3.24 years, and overall survival was 4.65 years. Parotid location, vascular invasion, facial nerve sacrifice, and extracapsular extension were associated with worse survival. This study provides practical information for counseling of patients who undergo surgery for a parotid mass and are found to have this aggressive malignancy.
涎腺导管癌(SDC)是一种罕见的涎腺恶性肿瘤,通常在晚期出现。此前尚未对低T分期的SDC患者的预后进行详细研究。我们查询了本机构的癌症数据库,确定了28例原位SDC或T1/T2期SDC患者。进行了回顾性病历审查,随后将临床病理特征与N分期、无病生存率和总生存率进行了比较。与既往报道一样,患者多为60多岁的男性,区域转移发生率较高。5年无病生存率和总生存率均为49%。无病生存期中位数为3.24年,总生存期中位数为4.65年。腮腺部位、血管侵犯、面神经牺牲和包膜外扩展与较差的生存率相关。本研究为接受腮腺肿块手术且被发现患有这种侵袭性恶性肿瘤的患者的咨询提供了实用信息。